Multimodal interaction with BCL-2 family proteins underlies the proapoptotic activity of PUMA BH3

Chemistry and Biology

Volumn 20, Issue 7, 2013, Pages 888-902

  Edwards, Amanda L ^a   Gavathiotis, Evripidis ^a   Labelle, James L ^a   Braun, Craig R ^a   Opoku Nsiah, Kwadwo A ^a   Bird, Gregory H ^a   Walensky, Loren D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1; PUMA PROTEIN;

APOPTOSIS; ARTICLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 7; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POROSITY; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBSTRATE SPECIFICITY;

EID: 84880911153     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.06.007     Document Type: Article

References (70)

1. R.S. Akhtar, Y. Geng, B.J. Klocke, C.B. Latham, A. Villunger, E.M. Michalak, A. Strasser, S.L. Carroll, and K.A. Roth BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death J. Neurosci. 26 2006 7257 7264
2. F. Bernal, A.F. Tyler, S.J. Korsmeyer, L.D. Walensky, and G.L. Verdine Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide J. Am. Chem. Soc. 129 2007 2456 2457
3. R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J.S. Boehm, J. Dobson, and M. Urashima The landscape of somatic copy-number alteration across human cancers Nature 463 2010 899 905
4. G.H. Bird, F. Bernal, K. Pitter, and L.D. Walensky Synthesis and biophysical characterization of stabilized alpha-helices of BCL-2 domains Methods Enzymol. 446 2008 369 386
5. G.H. Bird, W.C. Crannell, and L.D. Walensky Chemical synthesis of hydrocarbon-stapled peptides for protein interaction research and therapeutic targeting Curr. Protoc. Chem. Biol. 3 2011 99 117
6. C.R. Braun, J. Mintseris, E. Gavathiotis, G.H. Bird, S.P. Gygi, and L.D. Walensky Photoreactive stapled BH3 peptides to dissect the BCL-2 family interactome Chem. Biol. 17 2010 1325 1333
7. C.J. Brown, S.T. Quah, J. Jong, A.M. Goh, P.C. Chiam, K.H. Khoo, M.L. Choong, M.A. Lee, L. Yurlova, and K. Zolghadr Stapled peptides with improved potency and specificity that activate p53 ACS Chem. Biol. 8 2013 506 512
8. B.A. Callus, D.M. Moujallad, J. Silke, R. Gerl, A.M. Jabbour, P.G. Ekert, and D.L. Vaux Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins J. Mol. Biol. 384 2008 313 323
9. P.-F. Cartron, T. Gallenne, G. Bougras, F. Gautier, F. Manero, P. Vusio, K. Meflah, F.M. Vallette, and P. Juin The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA Mol. Cell 16 2004 807 818
10. P.E. Czabotar, D. Westphal, G. Dewson, S. Ma, C. Hockings, W.D. Fairlie, E.F. Lee, S. Yao, A.Y. Robin, and B.J. Smith Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis Cell 152 2013 519 531
11. H. Dai, A. Smith, X.W. Meng, P.A. Schneider, Y.P. Pang, and S.H. Kaufmann Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization J. Cell Biol. 194 2011 39 48
12. N.N. Danial, L.D. Walensky, C.Y. Zhang, C.S. Choi, J.K. Fisher, A.J. Molina, S.R. Datta, K.L. Pitter, G.H. Bird, and J.D. Wikstrom Dual role of proapoptotic BAD in insulin secretion and beta cell survival Nat. Med. 14 2008 144 153
13. C.L. Day, C. Smits, F.C. Fan, E.F. Lee, W.D. Fairlie, and M.G. Hinds Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1 J. Mol. Biol. 380 2008 958 971
14. F. Delaglio, S. Grzesiek, G.W. Vuister, G. Zhu, J. Pfeifer, and A. Bax NMRPipe: a multidimensional spectral processing system based on UNIX pipes J. Biomol. NMR 6 1995 277 293
15. H. Du, J. Wolf, B. Schafer, T. Moldoveanu, J.E. Chipuk, and T. Kuwana BH3 domains other than Bim and Bid can directly activate Bax/Bak J. Biol. Chem. 286 2011 491 501
16. M. Erlacher, E.M. Michalak, P.N. Kelly, V. Labi, H. Niederegger, L. Coultas, J.M. Adams, A. Strasser, and A. Villunger BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo Blood 106 2005 4131 4138
17. M. Erlacher, V. Labi, C. Manzl, G. Böck, A. Tzankov, G. Häcker, E. Michalak, A. Strasser, and A. Villunger Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction J. Exp. Med. 203 2006 2939 2951
18. A.V. Follis, J.E. Chipuk, J.C. Fisher, M.K. Yun, C.R. Grace, A. Nourse, K. Baran, L. Ou, L. Min, and S.W. White PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis Nat. Chem. Biol. 9 2013 163 168
19. T. Gallenne, F. Gautier, L. Oliver, E. Hervouet, B. Noël, J.A. Hickman, O. Geneste, P.-F. Cartron, F.M. Vallette, S. Manon, and P. Juin Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members J. Cell Biol. 185 2009 279 290
20. S.P. Garrison, D.C. Phillips, J.R. Jeffers, J.E. Chipuk, M.J. Parsons, J.E. Rehg, J.T. Opferman, D.R. Green, and G.P. Zambetti Genetically defining the mechanism of Puma- and Bim-induced apoptosis Cell Death Differ. 19 2012 642 649
21. E. Gavathiotis, M. Suzuki, M.L. Davis, K. Pitter, G.H. Bird, S.G. Katz, H.-C. Tu, H. Kim, E.H.-Y. Cheng, N. Tjandra, and L.D. Walensky BAX activation is initiated at a novel interaction site Nature 455 2008 1076 1081
22. E. Gavathiotis, D.E. Reyna, M.L. Davis, G.H. Bird, and L.D. Walensky BH3-triggered structural reorganization drives the activation of proapoptotic BAX Mol. Cell 40 2010 481 492
23. E. Gavathiotis, D.E. Reyna, J.A. Bellairs, E.S. Leshchiner, and L.D. Walensky Direct and selective small-molecule activation of proapoptotic BAX Nat. Chem. Biol. 8 2012 639 645
24. K.C. Goldsmith, M. Gross, S. Peirce, D. Luyindula, X. Liu, A. Vu, M. Sliozberg, R. Guo, H. Zhao, C.P. Reynolds, and M.D. Hogarty Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma Cancer Res. 72 2012 2565 2577
25. D.H. Gray, F. Kupresanin, S.P. Berzins, M.J. Herold, L.A. O'Reilly, P. Bouillet, and A. Strasser The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens Immunity 37 2012 451 462
26. S. Grzesiek, and A. Bax The importance of not saturating water in protein NMR: application to sensitivity enhancement and NOE measurements J. Am. Chem. Soc. 115 1993 12593 12594
27. J. Han, C. Flemington, A.B. Houghton, Z. Gu, G.P. Zambetti, R.J. Lutz, L. Zhu, and T. Chittenden Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals Proc. Natl. Acad. Sci. USA 98 2001 11318 11323
28. M.G. Hinds, C. Smits, R. Fredericks-Short, J.M. Risk, M. Bailey, D.C. Huang, and C.L. Day Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets Cell Death Differ. 14 2007 128 136
29. A.M. Jabbour, J.E. Heraud, C.P. Daunt, T. Kaufmann, J. Sandow, L.A. O'Reilly, B.A. Callus, A. Lopez, A. Strasser, D.L. Vaux, and P.G. Ekert Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim Cell Death Differ. 16 2009 555 563
30. J.R. Jeffers, E. Parganas, Y. Lee, C. Yang, J. Wang, J. Brennan, K.H. MacLean, J. Han, T. Chittenden, and J.N. Ihle Puma is an essential mediator of p53-dependent and -independent apoptotic pathways Cancer Cell 4 2003 321 328
31. B.A. Johnson Using NMRView to visualize and analyze the NMR spectra of macromolecules Methods Mol. Biol. 278 2004 313 352
32. H. Kim, H.C. Tu, D. Ren, O. Takeuchi, J.R. Jeffers, G.P. Zambetti, J.J. Hsieh, and E.H. Cheng Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis Mol. Cell 36 2009 487 499
33. T. Kuwana, L. Bouchier-Hayes, J.E. Chipuk, C. Bonzon, B.A. Sullivan, D.R. Green, and D.D. Newmeyer BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly Mol. Cell 17 2005 525 535
34. J.L. LaBelle, S.G. Katz, G.H. Bird, E. Gavathiotis, M.L. Stewart, C. Lawrence, J.K. Fisher, M. Godes, K. Pitter, A.L. Kung, and L.D. Walensky A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers J. Clin. Invest. 122 2012 2018 2031
35. E.S. Leshchiner, C.R. Braun, G.H. Bird, and L.D. Walensky Direct activation of full-length proapoptotic BAK Proc. Natl. Acad. Sci. USA 110 2013 E986 E995
36. A. Letai, M.C. Bassik, L.D. Walensky, M.D. Sorcinelli, S. Weiler, and S.J. Korsmeyer Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics Cancer Cell 2 2002 183 192
37. F. Llambi, T. Moldoveanu, S.W. Tait, L. Bouchier-Hayes, J. Temirov, L.L. McCormick, C.P. Dillon, and D.R. Green A unified model of mammalian BCL-2 protein family interactions at the mitochondria Mol. Cell 44 2011 517 531
38. X. Luo, Q. He, Y. Huang, and M.S. Sheikh Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation Cell Death Differ. 12 2005 1310 1318
39. A. Marintchev, D. Frueh, and G. Wagner NMR methods for studying protein-protein interactions involved in translation initiation Methods Enzymol. 430 2007 283 331
40. T. Moldoveanu, Q. Liu, A. Tocilj, M. Watson, G. Shore, and K. Gehring The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site Mol. Cell 24 2006 677 688
41. T. Moldoveanu, C.R. Grace, F. Llambi, A. Nourse, P. Fitzgerald, K. Gehring, R.W. Kriwacki, and D.R. Green BID-induced structural changes in BAK promote apoptosis Nat. Struct. Mol. Biol. 20 2013 589 597
42. G. Mustata, M. Li, N. Zevola, A. Bakan, L. Zhang, M. Epperly, J.S. Greenberger, J. Yu, and I. Bahar Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death Curr. Top. Med. Chem. 11 2011 281 290
43. K. Nakano, and K.H. Vousden PUMA, a novel proapoptotic gene, is induced by p53 Mol. Cell 7 2001 683 694
44. T. Oltersdorf, S.W. Elmore, A.R. Shoemaker, R.C. Armstrong, D.J. Augeri, B.A. Belli, M. Bruncko, T.L. Deckwerth, J. Dinges, and P.J. Hajduk An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435 2005 677 681
45. K. Pitter, F. Bernal, J. Labelle, and L.D. Walensky Dissection of the BCL-2 family signaling network with stabilized alpha-helices of BCL-2 domains Methods Enzymol. 446 2008 387 408
46. C. Reimertz, D. Kögel, A. Rami, T. Chittenden, and J.H.M. Prehn Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway J. Cell Biol. 162 2003 587 597
47. D. Ren, H.-C. Tu, H. Kim, G.X. Wang, G.R. Bean, O. Takeuchi, J.R. Jeffers, G.P. Zambetti, J.J.-D. Hsieh, and E.H.-Y. Cheng BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program Science 330 2010 1390 1393
48. C. Smits, P.E. Czabotar, M.G. Hinds, and C.L. Day Structural plasticity underpins promiscuous binding of the prosurvival protein A1 Structure 16 2008 818 829
49. A.J. Souers, J.D. Leverson, E.R. Boghaert, S.L. Ackler, N.D. Catron, J. Chen, B.D. Dayton, H. Ding, S.H. Enschede, and W.J. Fairbrother ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets Nat. Med. 19 2013 202 208
50. D. Steckley, M. Karajgikar, L.B. Dale, B. Fuerth, P. Swan, C. Drummond-Main, M.O. Poulter, S.S.G. Ferguson, A. Strasser, and S.P. Cregan Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis J. Neurosci. 27 2007 12989 12999
51. M.L. Stewart, E. Fire, A.E. Keating, and L.D. Walensky The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer Nat. Chem. Biol. 6 2010 595 601
52. M. Suzuki, R.J. Youle, and N. Tjandra Structure of Bax: coregulation of dimer formation and intracellular localization Cell 103 2000 645 654
53. K. Takada, D. Zhu, G.H. Bird, K. Sukhdeo, J.J. Zhao, M. Mani, M. Lemieux, D.E. Carrasco, J. Ryan, and D. Horst Targeted disruption of the BCL9/beta-catenin complex inhibits oncogenic Wnt signaling Sci Transl Med 4 2012 148ra117
54. C. Tse, A.R. Shoemaker, J. Adickes, M.G. Anderson, J. Chen, S. Jin, E.F. Johnson, K.C. Marsh, M.J. Mitten, and P. Nimmer ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor Cancer Res. 68 2008 3421 3428
55. R.T. Uren, G. Dewson, L. Chen, S.C. Coyne, D.C.S. Huang, J.M. Adams, and R.M. Kluck Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak J. Cell Biol. 177 2007 277 287
56. A. Villunger, E.M. Michalak, L. Coultas, F. Müllauer, G. Böck, M.J. Ausserlechner, J.M. Adams, and A. Strasser p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa Science 302 2003 1036 1038
57. A. Villunger, V. Labi, P. Bouillet, J. Adams, and A. Strasser Can the analysis of BH3-only protein knockout mice clarify the issue of 'direct versus indirect' activation of Bax and Bak? Cell Death Differ. 18 2011 1545 1546
58. L.D. Walensky Direct BAKtivation Nat. Struct. Mol. Biol. 20 2013 536 538
59. L.D. Walensky Playing FullBAK Cell Cycle 12 2013 1333 1334
60. L.D. Walensky, A.L. Kung, I. Escher, T.J. Malia, S. Barbuto, R.D. Wright, G. Wagner, G.L. Verdine, and S.J. Korsmeyer Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix Science 305 2004 1466 1470
61. L.D. Walensky, K. Pitter, J. Morash, K.J. Oh, S. Barbuto, J. Fisher, E. Smith, G.L. Verdine, and S.J. Korsmeyer A stapled BID BH3 helix directly binds and activates BAX Mol. Cell 24 2006 199 210
62. S.N. Willis, J.I. Fletcher, T. Kaufmann, M.F. van Delft, L. Chen, P.E. Czabotar, H. Ierino, E.F. Lee, W.D. Fairlie, and P. Bouillet Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak Science 315 2007 856 859
63. A. Wyttenbach, and A.M. Tolkovsky The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons J. Neurochem. 96 2006 1213 1226
64. J.R. Yates 3rd, J.K. Eng, A.L. McCormack, and D. Schieltz Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database Anal. Chem. 67 1995 1426 1436
65. K.S. Yee, and K.H. Vousden Contribution of membrane localization to the apoptotic activity of PUMA Apoptosis 13 2008 87 95
66. J.A. Yethon, R.F. Epand, B. Leber, R.M. Epand, and D.W. Andrews Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis J. Biol. Chem. 278 2003 48935 48941
67. J. Yu, and L. Zhang PUMA, a potent killer with or without p53 Oncogene 27 Suppl 1 2008 S71 S83
68. J. Yu, L. Zhang, P.M. Hwang, K.W. Kinzler, and B. Vogelstein PUMA induces the rapid apoptosis of colorectal cancer cells Mol. Cell 7 2001 673 682
69. J. Yu, W. Yue, B. Wu, and L. Zhang PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation Clin. Cancer Res. 12 2006 2928 2936
70. Y. Zhang, D. Xing, and L. Liu PUMA promotes Bax translocation by both directly interacting with Bax and by competitive binding to Bcl-X L during UV-induced apoptosis Mol. Biol. Cell 20 2009 3077 3087